BCLAF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.366000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.910800E-01
Normal-vs-Stage2
3.658400E-02
Normal-vs-Stage3
1.909810E-01
Normal-vs-Stage4
5.997800E-01
Stage1-vs-Stage2
6.318800E-01
Stage1-vs-Stage3
1.331010E-01
Stage1-vs-Stage4
4.274000E-01
Stage2-vs-Stage3
2.656200E-03
Stage2-vs-Stage4
1.479830E-01
Stage3-vs-Stage4
1.187710E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.903800E-02
Normal-vs-AfricanAmerican
4.631200E-01
Normal-vs-Asian
7.646500E-02
Caucasian-vs-AfricanAmerican
2.433600E-01
Caucasian-vs-Asian
2.933200E-01
AfricanAmerican-vs-Asian
1.772380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.694200E-02
Normal-vs-Female
5.521600E-02
Male-vs-Female
7.459000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.358800E-01
Normal-vs-Age(41-60Yrs)
1.626220E-01
Normal-vs-Age(61-80Yrs)
2.714000E-02
Normal-vs-Age(81-100Yrs)
4.735600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.600900E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.931000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.105000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.204400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.617800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.687200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.014070E-02
Normal-vs-Daily Drinker
2.423600E-01
Normal-vs-Weekly Drinker
2.407000E-01
Normal-vs-Occasional Drinker
3.587600E-01
Normal-vs-Social Drinker
2.158600E-01
Non Drinker-vs-Daily Drinker
7.172400E-01
Non Drinker-vs-Weekly Drinker
7.022000E-01
Non Drinker-vs-Occasional Drinker
1.393730E-02
Non Drinker-vs-Social Drinker
3.383600E-01
Daily Drinker-vs-Weekly Drinker
9.444200E-01
Daily Drinker-vs-Occasional Drinker
1.596060E-02
Daily Drinker-vs-Social Drinker
2.489000E-01
Weekly Drinker-vs-Occasional Drinker
2.573800E-02
Weekly Drinker-vs-Social Drinker
2.468600E-01
Occasional Drinker-vs-Social Drinker
3.917000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.183600E-02
Normal-vs-Grade 2
2.800000E-02
Normal-vs-Grade 3
1.410190E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.400200E-01
Grade 1-vs-Grade 3
6.646800E-01
Grade 1-vs-Grade 4
4.183600E-02
Grade 2-vs-Grade 3
9.872200E-01
Grade 2-vs-Grade 4
2.800000E-02
Grade 3-vs-Grade 4
1.410190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.753400E-01
Normal-vs-NonDiabetic
3.652400E-02
Diabetic-vs-NonDiabetic
3.588600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.053000E-01
Normal-vs-NoPancreatitis
3.914200E-02
Pancreatitis-vs-NoPancreatitis
3.560900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.117590E-01
Normal-vs-N1
3.489800E-02
N0-vs-N1
4.549800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.637400E-01
Normal-vs-TP53-NonMutant
2.734600E-01
TP53-Mutant-vs-TP53-NonMutant
1.054390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
